Can I Take Green Tea Extract (EGCG) with Finasteride?

What Is the Interaction Between Green Tea Extract and Finasteride?

The combination of green tea extract and finasteride does not trigger a major pharmacokinetic drug-supplement interaction. Finasteride is metabolized primarily by hepatic CYP3A4, and EGCG is not a strong inhibitor or inducer of that enzyme at typical supplement doses [1]. The clinically meaningful concern is pharmacodynamic: both compounds place independent stress on hepatic tissue at high doses, and combining them raises the theoretical risk of elevated liver enzymes or, in rare cases, drug-induced liver injury (DILI).

Finasteride and Liver Metabolism

Finasteride undergoes extensive first-pass hepatic metabolism. Two inactive metabolites are excreted in bile. In clinical trials supporting FDA approval, liver enzyme elevations were uncommon at standard doses (1 mg for androgenetic alopecia, 5 mg for benign prostatic hyperplasia), but the prescribing information does note hepatic processing as a relevant pharmacological consideration [2].

EGCG and Hepatotoxicity: What the Evidence Shows

High-dose EGCG supplements are not the same as brewed green tea. A brewed cup of green tea contains roughly 50 to 100 mg of EGCG. Concentrated green tea extract capsules often deliver 400 to 800 mg or more per serving [3].

The European Food Safety Authority (EFSA) conducted a systematic review in 2018 and concluded that green tea catechin intakes above 800 mg/day are associated with signals of liver toxicity, based on case reports and human intervention data [4]. A 2020 analysis in the journal Antioxidants reviewed 78 case reports of green tea extract-related liver injury and found that the majority involved products delivering more than 700 mg EGCG daily [5].

Why the Combination Deserves Attention

Neither compound alone commonly causes serious liver injury at labeled doses. Together, though, any pre-existing subclinical hepatic inflammation could be amplified. A 2019 review in Drug Safety identified polyphenol-rich botanical supplements as a distinct category of DILI triggers, noting that co-administration with other hepatically processed drugs increases individual susceptibility [6].

How Does EGCG Affect CYP Enzymes Relevant to Finasteride?

EGCG inhibits several CYP isoforms in vitro, but translation to clinically meaningful in vivo effects at typical supplement doses is limited.

CYP3A4 Inhibition: Real or Theoretical?

Finasteride relies on CYP3A4 for metabolism. In vitro studies show EGCG can inhibit CYP3A4 activity, but the inhibition constant (Ki) values reported are in the micromolar range that requires supraphysiologic tissue concentrations not reliably achieved with oral supplementation [7]. A 2012 pharmacokinetic study published in Drug Metabolism and Pharmacokinetics found that green tea extract at 300 mg/day did not significantly alter midazolam (a CYP3A4 probe) pharmacokinetics in healthy volunteers [8].

CYP1A2 and Other Pathways

EGCG shows more consistent inhibition of CYP1A2 in human microsomal assays [9]. Finasteride does not rely on CYP1A2, so this pathway is not directly relevant to the finasteride-EGCG pairing. Still, patients taking other medications that use CYP1A2 (theophylline, clozapine, certain antidepressants) alongside both finasteride and high-dose EGCG should flag this to their prescriber.

P-glycoprotein and Absorption Effects

EGCG may modulate P-glycoprotein (P-gp) activity [10]. Finasteride is a P-gp substrate to a limited degree. At realistic supplemental EGCG doses, this interaction is unlikely to alter finasteride plasma concentrations enough to change clinical outcomes, but it represents one more reason to avoid very high-dose EGCG products.

What Dose of Green Tea Extract Is Safe to Take with Finasteride?

Dose is the deciding variable. Brewed tea is low-risk. High-dose capsules carry meaningful hepatic risk on their own, and that risk is not eliminated by taking them alongside a prescription drug.

Brewed Green Tea: Negligible Risk

Drinking 2 to 4 cups of brewed green tea per day delivers roughly 100 to 400 mg of total catechins, with EGCG making up approximately 50 to 60% of that fraction [11]. This range sits well below the 800 mg EGCG threshold identified in the EFSA review [4]. Patients on finasteride do not need to restrict brewed tea consumption.

Low-Dose Supplements: Generally Acceptable With Monitoring

Supplements delivering 200 to 400 mg EGCG per day occupy a gray zone. The EFSA safety opinion notes that "intake of EGCG from green tea supplements of 800 mg/day and above raises safety concerns" [4], implying that doses below that threshold are less concerning, though not risk-free in all individuals.

A practical clinical framework for patients on finasteride who want to use EGCG:

| EGCG Source | Approximate Daily EGCG | Risk Level | Action | |---|---|---|---| | Brewed green tea (2 to 4 cups) | 100 to 300 mg | Low | No restriction needed | | Low-dose supplement | 200 to 400 mg | Low to moderate | Baseline LFTs; recheck at 6 to 8 weeks | | Standard supplement capsule | 400 to 800 mg | Moderate | Avoid unless medically supervised | | High-dose / concentrated extract | >800 mg | High | Avoid with any hepatically processed drug |

Products to Avoid

Several green tea extract products marketed for weight loss or metabolic health deliver 1,000 mg or more of EGCG per serving. The FDA has received adverse event reports linking such products to acute liver failure [12]. Patients on finasteride should read supplement labels carefully and avoid products that do not specify EGCG content.

Does Green Tea Extract Help or Hurt Hair Loss Treatment?

This question is clinically relevant because many patients taking finasteride for androgenetic alopecia also take EGCG specifically for its proposed anti-hair-loss properties.

EGCG and 5-Alpha Reductase Inhibition

EGCG has shown 5-alpha reductase inhibitory activity in cell-based assays. A 2007 study in Journal of Dermatology found that EGCG inhibited type II 5-alpha reductase in vitro at concentrations achievable in dermal tissue [13]. This means EGCG may share a pharmacodynamic mechanism with finasteride.

Does Additive 5-Alpha Reductase Inhibition Help?

Theoretically, if EGCG adds mild 5-alpha reductase inhibition on top of finasteride's established activity, some additional DHT suppression could result. In practice, finasteride 1 mg already suppresses serum DHT by approximately 70% and scalp DHT by approximately 64% according to the original phase III trials [14]. Whether modest additional inhibition from EGCG translates to clinical hair benefit has not been tested in a randomized controlled trial.

EGCG for Hair Growth: Human Evidence

A 2016 randomized pilot study (N=10) in Phytomedicine found that topical EGCG application improved hair growth scores after 4 weeks compared to vehicle control, with proposed mechanisms including IGF-1 upregulation in dermal papilla cells [15]. Oral EGCG human RCT data for androgenetic alopecia does not exist at adequate scale. Patients should not substitute EGCG for finasteride based on current evidence.

Monitoring: What to Check If You Take Both

Liver function monitoring is the centerpiece of safe co-use. The monitoring approach below reflects standard DILI surveillance principles outlined by the American College of Gastroenterology and drug-induced liver injury network (DILIN) data [16].

Baseline Testing

Before starting any green tea extract supplement while on finasteride, obtain:

• Alanine aminotransferase (ALT)
• Aspartate aminotransferase (AST)
• Total bilirubin
• Alkaline phosphatase (ALP)

If any value is already elevated above the upper limit of normal, reconsider adding EGCG supplements until the elevation is explained and resolved.

Follow-Up Schedule

Recheck ALT and AST at 6 to 8 weeks after starting the supplement. A rise of more than 3x the upper limit of normal (3x ULN) is the threshold used by the FDA for DILI signal detection [17]. At that level, discontinue the EGCG supplement immediately and contact your prescriber.

Symptoms to Watch

Liver injury from supplements often presents with fatigue and right upper quadrant discomfort before lab values change substantially. Jaundice, dark urine, or pale stools are late signs requiring urgent evaluation. Patients combining any supplement with a prescription medication should not wait for scheduled labs if these symptoms appear.

Practical Guidance: What to Tell Your Doctor

Most physicians prescribing finasteride for hair loss or BPH do not routinely ask about supplement use. Patients need to raise the topic themselves.

What to Disclose

Tell your prescriber the exact product name, the serving size, and the EGCG content per serving. "I take green tea" is not enough information. "I take 400 mg EGCG from a standardized green tea extract capsule once daily" gives your clinician something to work with.

Timing and Separation

There is no established dose-separation window that neutralizes the hepatic risk. Unlike pharmacokinetic interactions where timing can reduce peak plasma overlap, the pharmacodynamic hepatic stress concern with EGCG is not meaningfully changed by taking it at a different time of day from finasteride. The relevant variable is daily EGCG dose, not timing.

Stopping EGCG Before Lab Work

Some clinicians recommend pausing high-dose EGCG supplementation for 2 weeks before any scheduled liver function panel if the patient has been using a product above 400 mg/day. This reduces the chance that transient EGCG-related enzyme elevations are attributed to finasteride and leads to unnecessary finasteride discontinuation.

Special Populations: Who Should Be More Cautious?

Certain patients face higher baseline risk when combining these agents.

Pre-Existing Liver Conditions

Patients with nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease, or elevated transaminases from any cause should avoid EGCG supplements above 200 mg/day while on finasteride. The 2018 EFSA panel specifically noted that individuals with pre-existing hepatic vulnerability showed injury signals at lower EGCG doses than healthy volunteers [4].

Concomitant Hepatotoxic Medications

Statins, azole antifungals, and certain antibiotics (including isoniazid) also carry hepatotoxicity risk. Adding high-dose EGCG to an existing regimen that includes one of these drugs along with finasteride stacks risk beyond what any single agent would produce alone [6].

Alcohol Use

Alcohol is an independent hepatotoxin. Patients who consume more than 14 standard drinks per week should not use concentrated EGCG supplements, regardless of finasteride use. The interaction between ethanol and polyphenol-rich botanical extracts on liver enzyme induction is additive in animal models [18].

Key Takeaways for Patients and Clinicians

Green tea brewed from leaves carries negligible risk when taken with finasteride. Concentrated EGCG supplements above 800 mg/day carry documented hepatotoxicity risk independent of finasteride, and that risk is not eliminated by the relatively minor CYP3A4 overlap between the two. Doses of 200 to 400 mg EGCG daily from a standardized supplement require baseline and follow-up liver function testing.

The 2018 EFSA scientific opinion states directly: "green tea preparations providing doses of EGCG above 800 mg/day are associated with signs of liver toxicity in susceptible individuals" [4]. That threshold is the clearest guidance available.

Prescribers should ask about supplement use at every finasteride follow-up visit. The Natural Medicines Database classifies the green tea extract-drug-induced liver injury interaction as "possible" at high doses, a rating that warrants active monitoring rather than either blanket avoidance or blanket reassurance [19].

Obtain baseline ALT and AST before starting any EGCG supplement if you are on finasteride, and recheck at 8 weeks.